Back

The role of circulating lymphocytes on hypertensive heart disease

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 7 - Hypertension - Miscellaneous Target Organ Damage/Left Ventricular Hypertrophy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Klaus-Dieter Schlueter

Justus-Liebig University of Giessen, Giessen (Germany)

16 More presentations in this session

Presentation thumbnail
Impact of the 2017 AHA/ACC hypertension guideline on hypertension prevalence and cardiovascular risk factors in a healthy older cohort
Doctor E. Chowdhury (Perth, AU)
Abstract Slides
Presentation thumbnail
Achieved blood pressure and cardiovascular outcomes in hypertensives
Doctor N. Lim (Cheongju, KR)
Abstract
Presentation thumbnail
Challenges of implementation of new European Guidelines 2018 on hypertension in a real clinical practice
Doctor A. Alieva (Saint Petersburg, RU)
Abstract
Presentation thumbnail
Contrasting the impact of the european (ESC/ESH 2018) versus american (ACC/AHA 2017) high blood pressure clinical practice guidelines in poland
Mr A. Wyszomirski (Gdansk, PL)
Abstract
Presentation thumbnail
High blood pressure cut-off by 130/80 mmHg in middle-ages may be valid for predicting heart failure in ages of seventies.
Doctor N. Sasaki (Hiroshima, JP)
Abstract

Access the full session

Session thumbnail
Poster Session 7 - Hypertension - Miscellaneous

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Congress Presentation
How does imaging guide management in my patients with hypertension?
thumbnail
Congress Presentation
Arterial hypertension
thumbnail
Congress Presentation
Left ventricular hypertrophy, wall thickness, and histological myocyte alteration in end-stage heart failure: a call for a standard definition

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources